Rhinocort is a nasal corticosteroid spray used to treat allergic rhinitis. Therapeutically it reduces inflammation of the nasal mucosa causing symptoms such as congestion, sneezing, and itching to subside. The drug's active ingredient, budesonide, is a synthetic glucocorticoid that binds to intracellular corticosteroid receptors and modulates gene transcription. This action suppresses the release of inflammatory mediators like histamine and leukotrienes, decreasing vascular permeability and swelling. As a result, airway airflow improves and the user experiences relief from seasonal or perennial allergy symptoms. The medication works locally in the nasal passages while minimally affecting systemic hormone levels when used as directed.

Pharmacodynamics and pharmacological profile of Rhinocort describe the medication's interaction with biological systems. It is a synthetic corticosteroid formulated for topical application in the nasal cavity. The drug binds selectively to glucocorticoid receptors present on respiratory mucosal cells. This binding suppresses the transcription of inflammatory genes and reduces the production of cytokines. As a result, the inflammatory response in the nasal lining is attenuated, leading to decreased swelling and mucus secretion. The clinical therapeutic role of Rhinocort is to relieve symptoms such as congestion, sneezing, and nasal itching associated with allergic rhinitis. Its prolonged anti-inflammatory effect supports sustained control of chronic nasal inflammation without significant systemic absorption. Overall, the medication achieves its intended effect by modulating intracellular signaling pathways that mediate allergic inflammation.

Common side effects of Rhinocort may include a mild headache. Some users experience nasal irritation or a dry feeling in the nose. Occasional nosebleeds can occur, especially when blowing the nose frequently. A sore throat or cough may develop as the spray dries the throat lining. Changes in taste sensation have been reported in a small number of cases. Some individuals notice mild fatigue or headache that persists after use. These effects are generally temporary and tend to resolve with continued use.

Some people may experience nasal dryness or irritation after using Rhinocort. Others might notice mild nosebleeds or sore throat. Headaches can also occur in a small number of users. Occasional dizziness or a metallic taste has been reported. Some individuals may notice increased thirst or mild stomach discomfort. Rarely, visual disturbances such as blurred vision have been observed. Most side effects are temporary and often improve with continued use.